Current state of renal transplant immunosuppression: Present and future

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

708

HTML

7510

Tables (1-6)

197

Sum=8415

Aug 24, 2012 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Clinical Practice

World J Transplant. Aug 24, 2012; 2(4): 51-68
Published online Aug 24, 2012. doi: 10.5500/wjt.v2.i4.51

Table 4 Comparative adverse effects of prolonged release Tacrolimus and Tacrolimus (%)

ADR	Prolonged released Tacrolimus	Tacrolimus twice daily
Gastrointestinal
Diarrhea	45.3	44.3
Loose stools	5.1	7.1
Metabolism and nutritional
Hyperlipidemia	16.4	17.5
Diabetes mellitus	14.0	11.3
Hyponatremia	2.8	0.9
Infections and infestations
Sinusitis	7.0	3.3
Gastroenteritis	6.5	0.5
Peripheral edema	35.5	34.9
Nervous system
Tremor	35.0	34.4
Paraesthesia	5.6	1.4
Vascular
Orthostatasis	7.0	4.7
Lymphocele	0.5	0.9
Psychiatric
Insomnia	25.7	30.2
Skin
Alopecia	6.5	7.1

Citation: Kalluri HV, Hardinger KL. Current state of renal transplant immunosuppression: Present and future. World J Transplant 2012; 2(4): 51-68
URL: https://www.wjgnet.com/2220-3230/full/v2/i4/51.htm
DOI: https://dx.doi.org/10.5500/wjt.v2.i4.51